Implementation of Coordinated Global Oral Poliovirus Vaccine Serotype 2 Cessation: Risks of Inadvertent Trivalent Oral Poliovirus Vaccine Use
by Radboud J. Duintjer Tebbens, Lee M. Hampton, and Kimberly M. Thompson, BMC Infectious Diseases 2016; 16:237, doi: 10.1186/s12879-016-1537-8.

Answers to frequently asked questions

What are the study’s main findings?
What are the study’s main recommendations?
Background on polio

What are the study’s main findings?

What are the study’s main recommendations?